Fraunhofer Institute for Biomedical EngineeringMedical Biotechnology
Press Releases
- The mobile Fraunhofer IBMT epidemiological laboratory (epiLab) in use for nationwide early detection and prevention of SARS-CoV-2 infections
- New screening approach in the fight against viruses
- Fraunhofer IBMT in EC-FET Open Project GLADIATOR - New technologies for cancer monitoring
- Meet Fraunhofer IBMT at BIO International Convention, Philadelphia, USA, 2019: Stem cell applications - Application-specific high-throughput production processes revolutionize industrial new drug testing
- Fraunhofer three times in joint action - Laboratory technology and biotechnology in the mobile epidemiological BSL2 laboratory, the so-called mobile EpiLab
- EBiSC2 – The European Bank for induced pluripotent Stem Cells launches a second project phase to become a self-sustainable repository for human induced pluripotent stem cells (hiPSC), extend the existing cell catalogue, and offer additional hiPSC-related services
- Committed to Highest Quality: Laboratories of Medical Biotechnology of the Fraunhofer IBMT certified and accredited
- Fraunhofer IBMT at ACHEMA 2018 – Saarland pavilion hall 5.1D89 - Process technology, medical biotechnology, process monitoring and control – The Fraunhofer Institute for Biomedical Engineering IBMT shows new research and development
- MEDICA 2017: Laboratory in a bag - Growing human stem cells
- HISENTS: Multi-Organ Platform for Risk Assessment of Nanomaterials
- Project NanoUmwelt - Detecting Minute Nano Amounts in Environmental Samples
- Launch of the new European Stem Cell Bank - EBiSC European Bank for induced pluripotent Stem Cells
- Growing Stem Cells faster on Seaweed
- On the Track of Nanomaterials - Researchers pave the way for realistic risk assessment of nanomaterials in the environment
- Central Biobank for Drug Research